Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Price Passes Below 200-Day Moving Average of $7.61

Bavarian Nordic A/S (OTCMKTS:BVNRY)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $7.61 and traded as low as $7.45. Bavarian Nordic A/S shares last traded at $7.45, with a volume of 3,767 shares trading hands.

Bavarian Nordic A/S Price Performance

The stock has a market cap of $1.75 billion, a PE ratio of 7.84 and a beta of 1.50. The business has a fifty day moving average of $7.50 and a 200-day moving average of $7.61.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last issued its earnings results on Wednesday, March 6th. The company reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.44 by $0.12. Bavarian Nordic A/S had a return on equity of 0.07% and a net margin of 20.80%. The business had revenue of $353.27 million during the quarter, compared to analysts’ expectations of $340.71 million. As a group, equities research analysts predict that Bavarian Nordic A/S will post 0.52 EPS for the current year.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.